Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 211 AL 225

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative

Karikari TK, Benedet AL, Ashton NJ, Lantero Rodriguez J, Snellman A, Suárez-Calvet M, Saha-Chaudhuri P, Lussier F, Kvartsberg H, Rial AM, Pascoal TA, Andreasson U, Schöll M, Weiner MW, Rosa-Neto P, Trojanowski JQ, Shaw LM, Blennow K, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative.

Mol Psychiatry. 2021 Feb;26(2):429-442. doi: 10.1038/s41380-020-00923-z. Epub 2020 Oct 26.

Novel biomarkers in Alzheimer's disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

Navas-Carrillo D, Rivera-Caravaca JM, Sampedro-Andrada A, Orenes-Piñero E.

Crit Rev Clin Lab Sci. 2021 May;58(3):167-179. doi: 10.1080/10408363.2020.1833298. Epub 2020 Nov 2.

The relationship between neurofilament light chain and cognition in neurological disorders: A scoping review

Ramani S, Berard JA, Walker LAS.

J Neurol Sci. 2021 Jan 15;420:117229. doi: 10.1016/j.jns.2020.117229. Epub 2020 Nov 24.

A Multilevel View of the Development of Alzheimer's Disease

Avila J, Perry G.

Neuroscience. 2021 Mar 1;457:283-293. doi: 10.1016/j.neuroscience.2020.11.015. Epub 2020 Nov 24.

The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation

Cisbani G, Bazinet RP.

Prostaglandins Leukot Essent Fatty Acids. 2021 Jan;164:102205. doi: 10.1016/j.plefa.2020.102205. Epub 2020 Nov 19.

Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Mimura Y, Nishida H, Nakajima S, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y.

Neurosci Biobehav Rev. 2021 Feb;121:47-59. doi: 10.1016/j.neubiorev.2020.12.003. Epub 2020 Dec 8.

Comparing fluid biomarkers of Alzheimer's disease between African American or Black African and white groups: A systematic review and meta-analysis

Chaudhry A, Rizig M.

J Neurol Sci. 2021 Feb 15;421:117270. doi: 10.1016/j.jns.2020.117270. Epub 2020 Dec 15.

Inclusion of ethnoracial populations and diversity remains a key challenge in Alzheimer's disease biofluid-based biomarker studies

Babulal GM.

J Neurol Sci. 2021 Feb 15;421:117269. doi: 10.1016/j.jns.2020.117269. Epub 2020 Dec 14.

European Academy of Neurology/European Alzheimer's Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment

Frederiksen KS, Nielsen TR, Winblad B, Schmidt R, Kramberger MG, Jones RW, Hort J, Grimmer T, Georges J, Frölich L, Engelborghs S, Dubois B, Waldemar G.

Eur J Neurol. 2021 Jul;28(7):2147-2155. doi: 10.1111/ene.14668. Epub 2020 Dec 23.

Blood biomarkers in Alzheimer's disease

Altuna-Azkargorta M, Mendioroz-Iriarte M.

Neurologia (Engl Ed). 2021 Nov-Dec;36(9):704-710. doi: 10.1016/j.nrleng.2018.03.006. Epub 2020 Feb 19.

The complement cascade in Alzheimer's disease: a systematic review and meta-analysis

Krance SH, Wu CY, Zou Y, Mao H, Toufighi S, He X, Pakosh M, Swardfager W.

Mol Psychiatry. 2021 Oct;26(10):5532-5541. doi: 10.1038/s41380-019-0536-8. Epub 2019 Oct 18.

Melatonin Receptor as a Drug Target for Neuroprotection

Wongprayoon P, Govitrapong P.

Curr Mol Pharmacol. 2021;14(2):150-164. doi: 10.2174/1874467213666200421160835.

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer's and Parkinson's Diseases

Mayo S, Benito-León J, Peña-Bautista C, Baquero M, Cháfer-Pericás C.

Curr Neuropharmacol. 2021;19(8):1273-1303. doi: 10.2174/1570159X19666201223154009.

Editorial to the Special Issue "Lipidomics and Neurodegenerative Diseases"

Calvano CD, Losito I, Cataldi T.

Int J Mol Sci. 2021 Jan 28;22(3):1270. doi: 10.3390/ijms22031270.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias